Ventas Inc(VTR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 4:19 PM ET (Korea 10/29 05:19)
Full metrics table
| Index | S&P 500 | P/E | 153.34 | EPS (ttm) | 0.53 | Insider Own | 0.54% | Shs Outstand | 528.8M | Perf Week | -5.05% |
| Market Cap | 42.51B | Forward P/E | 85.6 | EPS next Y | 60.65% | Insider Trans | 0.05% | Shs Float | 510.2M | Perf Month | -6.72% |
| Enterprise Value | 55.49B | PEG | 2.59 | EPS next Q | 0.17 | Inst Own | 105.14% | Short Float | 2.83% | Perf Quarter | -11.8% |
| Income | 0.26B | P/S | 6.27 | EPS this Y | 9.18% | Inst Trans | 3.41% | Short Ratio | 4.03 | Perf Half Y | -7.21% |
| Sales | 6.78B | P/B | 2.71 | EPS next 5Y | 33.02% | ROA | 0.91% | Short Interest | 14.44M | Perf YTD | 4.77% |
| Book/sh | 29.89 | P/C | 185.12 | EPS past 3/5Y | - -14.17% | ROE | 1.86% | 52W High | -20.21% ($101.60) | Perf Year | 15.73% |
| Cash/sh | 0.44 | P/FCF | 29.49 | Sales past 3/5Y | 12.23% 8.99% | ROIC | 0.92% | 52W Low | 18.96% ($68.15) | Perf 3Y | 97.33% |
| Dividend Est. | $2.08 (2.57%) | EV/EBITDA | 22.54 | EPS Y/Y TTM | 26.45% | Gross Margin | 17.29% | Volatility(W/M) | 2.43% 2.26% | Perf 5Y | 48.9% |
| Dividend TTM | 2.04 | EV/Sales | 8.18 | Sales Y/Y TTM | 22.13% | Oper. Margin | 13.86% | ATR (14) | 2.29 | Perf 10Y | 23.75% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 0.71 | EPS Q/Q | -11.58% | Profit Margin | 3.86% | RSI (14) | 36.73 | Recom | 1.5 |
| Dividend Gr. 3/5Y | 2.17% -2.15% | Current Ratio | 3.17 | Sales Q/Q | 23.02% | SMA20 | -3.44% ($83.96) | Beta | 0.79 | Target Price | $100 |
| Payout | 353.33% | Debt/Eq | 0.8 | Earnings | 2026/10/27 | SMA50 | -7.3% ($87.45) | Rel Volume | 1.72 | Prev Close | $83.34 |
| Employees | 542 | LT Debt/Eq | 0.8 | EPS/Sales Surpr. | -19.8% 3.57% | SMA200 | -6.24% ($86.47) | Avg Volume(3M) | 3.58M | Price | $81.07 |
| IPO | 1989/9/19 | Option/Short | Yes/Yes | Trades | 41448 | Volume | 6,164,171 | Change | -2.72% |
🏥 This is a major U.S. healthcare REIT that operates senior housing, medical office buildings, and life science research facilities. Since its spin-off launch in 1998, it has managed an extensive healthcare real estate portfolio across North America and the United Kingdom, with a focus on senior housing, and is widely regarded as a key beneficiary of population aging trends.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded more than usual. That is 172% of its average volume.
VTR has a sound balance sheet but weak earning power
After all costs, only $3.86 of every $100 in sales is left.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.2% this year.
Tap to view numbers
However, it looks expensive
For a company expected to earn $100 next year, you would pay $8,560. Peers typically go for $3,139. It is about in line with its own 3-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +48.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 2.57% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 105.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 17 in the industry
Based on market cap of $43B.
FAQ
What kind of company is VTR?
VTR belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of VTR?
The market cap of VTR is approximately $42.5B, ranking 370 within its sector.
Does VTR pay dividends?
VTR has a dividend yield of approximately 2.57%, with an annual dividend of $2.08.
What is the P/E ratio of VTR?
VTR has a P/E ratio of approximately 153.3x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for VTR?
VTR has recorded a 52-week high of $101.60 and a low of $68.15.
